<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24731551</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>31</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2253-8070</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>4</Issue><PubDate><Year>2014</Year><Season>Jul-Aug</Season></PubDate></JournalIssue><Title>Revista espanola de medicina nuclear e imagen molecular</Title><ISOAbbreviation>Rev Esp Med Nucl Imagen Mol</ISOAbbreviation></Journal><ArticleTitle>[Functional neuroimaging in the diagnosis of patients with Parkinsonism: Update and recommendations for clinical use].</ArticleTitle><Pagination><StartPage>215</StartPage><EndPage>226</EndPage><MedlinePgn>215-26</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.remn.2014.02.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2253-654X(14)00044-4</ELocationID><Abstract><AbstractText>Functional Neuroimaging has been traditionally used in research for patients with different Parkinsonian syndromes. However, the emergence of commercial radiotracers together with the availability of single photon emission computed tomography (SPECT) and, more recently, positron emission tomography (PET) have made them available for clinical practice. Particularly, the development of clinical evidence achieved by functional neuroimaging techniques over the past two decades have motivated a progressive inclusion of several biomarkers in the clinical diagnostic criteria for neurodegenerative diseases that occur with Parkinsonism. However, the wide range of radiotracers designed to assess the involvement of different pathways in the neurodegenerative process underlying Parkinsonian syndromes (dopaminergic nigrostriatal pathway integrity, basal ganglia and cortical neuronal activity, myocardial sympathetic innervation), and the different neuroimaging techniques currently available (scintigraphy, SPECT and PET), have generated some controversy concerning the best neuroimaging test that should be indicated for the differential diagnosis of Parkinsonism. In this article, a panel of nuclear medicine and neurology experts has evaluated the functional neuroimaging techniques emphazising practical considerations related to the diagnosis of patients with uncertain origin parkinsonism and the assessment Parkinson's disease progression.</AbstractText><CopyrightInformation>Copyright &#xa9; 2014 Elsevier Espa&#xf1;a, S.L. and SEMNIM. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arbizu</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Grupo de Trabajo de Neuroimagen de la SEMNIM, Servicio de Medicina Nuclear, Cl&#xed;nica Universidad de Navarra, Pamplona, Espa&#xf1;a. Electronic address: jarbizu@unav.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luquin</LastName><ForeName>M R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Grupo de Trastornos del Movimiento de la SEN, Departamento de Neurolog&#xed;a, Cl&#xed;nica Universidad de Navarra, Pamplona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abella</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Servicio de Neurolog&#xed;a, Hospital A, Marcide, Ferrol, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de la Fuente-Fern&#xe1;ndez</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Servicio de Neurolog&#xed;a, Hospital A, Marcide, Ferrol, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandez-Torr&#xf3;n</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Servicio de Neurolog&#xed;a, Hospital Universitario Donostia, &#xc1;rea de Neurociencias, Instituto de Investigaci&#xf3;n Biodonostia, CIBERNED, San Sebasti&#xe1;n, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Sol&#xed;s</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Nuclear, UDIM, Hospital Universitario Virgen del Roc&#xed;o, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Sevilla, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garrastachu</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Nuclear, Hospital San Pedro, CIBIR, Logro&#xf1;o, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jim&#xe9;nez-Hoyuela</LastName><ForeName>J M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Nuclear, Hospital Universitario Virgen de la Victoria, M&#xe1;laga, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Llaneza</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Servicio de Neurolog&#xed;a, Hospital A, Marcide, Ferrol, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lome&#xf1;a</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Nuclear, Hospital Clinic, Barcelona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorenzo-Bosquet</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Nuclear, Hospital Vall d&#x301;Hebron, CETIR-ERESA, Unitat Teknon, Barcelona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;</LastName><ForeName>M J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Unidad de Parkinson y Trastornos del Movimiento, Servicio de Neurolog&#xed;a, ICN, CIBERNET, Hospital Clinic, Barcelona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez-Castrillo</LastName><ForeName>J C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Servicio de Neurolog&#xed;a, Hospital Ram&#xf3;n y Cajal, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mir</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Unidad de Trastornos del Movimiento, Servicio de Neurolog&#xed;a y Neurofisiolog&#xed;a Cl&#xed;nica, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Roc&#xed;o, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Sevilla, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitjavila</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Nuclear, Hospital Universitario Puerta de Hierro, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz-Mart&#xed;nez</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Unidad de Parkinson y otros Trastornos del Movimiento, Servicio de Neurolog&#xed;a, Hospital Universitario Donostia, CIBERNED, Instituto de Salud Carlos III, San Sebasti&#xe1;n (Guip&#xfa;zcoa), Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vela</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Servicio de Neurolog&#xed;a, Hospital Universitario Fundaci&#xf3;n Alcorc&#xf3;n, Alcorc&#xf3;n, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Neuroimagen funcional en el diagn&#xf3;stico de pacientes con s&#xed;ndrome parkinsoniano: actualizaci&#xf3;n y recomendaciones para el uso cl&#xed;nico.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2014</Year><Month>04</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rev Esp Med Nucl Imagen Mol</MedlineTA><NlmUniqueID>101585329</NlmUniqueID><ISSNLinking>2253-654X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059907" MajorTopicYN="Y">Functional Neuroimaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020734" MajorTopicYN="N">Parkinsonian Disorders</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049268" MajorTopicYN="Y">Positron-Emission Tomography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015899" MajorTopicYN="Y">Tomography, Emission-Computed, Single-Photon</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Diagn&#xf3;stico diferencial</Keyword><Keyword MajorTopicYN="N">Differential diagnosis</Keyword><Keyword MajorTopicYN="N">Enfermedad de Parkinson</Keyword><Keyword MajorTopicYN="N">Gammagraf&#xed;a</Keyword><Keyword MajorTopicYN="N">PET</Keyword><Keyword MajorTopicYN="N">Parkinson disease</Keyword><Keyword MajorTopicYN="N">Parkinsonism</Keyword><Keyword MajorTopicYN="N">Parkinsonismo</Keyword><Keyword MajorTopicYN="N">SPECT</Keyword><Keyword MajorTopicYN="N">Scintigraphy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24731551</ArticleId><ArticleId IdType="doi">10.1016/j.remn.2014.02.001</ArticleId><ArticleId IdType="pii">S2253-654X(14)00044-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>